基于石的药物通过破坏铁的平衡来使Pseudomonas aeruginosa对多种抗生素敏感
Yushan Xia1,2,3, Xueying Wei1, Peng Gao4
1Department of Chemistry, State Key Laboratory of Synthetic Chemistry, CAS-HKU Joint Laboratory of Metallomics on Health and Environment, The University of Hong Kong, Hong Kong, China.
Nature microbiology
|September 18, 2024
概括
与抗生素结合的比斯穆特药物有效地消除了多药耐药的Pseudomonas aeruginosa感染. 这种组合疗法具有低毒性,并防止进一步发展抗生素耐药性.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 由于抗生素耐药性的快速发展,Pseudomonas aeruginosa感染带来了重大治疗挑战.
- 重新利用现有的药物,比如珠化合物,提供了对抗耐药细菌的可行策略.
研究的目的:
- 评估结合木基药物与抗生素对抗多药耐药Pseudomonas aeruginosa的疗效.
- 调查斯木提升抗生素活性的机制,并评估毒性.
主要方法:
- 对结石化合物 (结石亚盐酸盐,结石亚酸盐) 与各种抗生素类对抗P. aeruginosa的协同活性测试.
- 机理学研究涉及铁稳态破坏,电子运输链抑制和排泄活动.
- 活体细菌病和活体老鼠肺部感染模型,以评估疗效和毒性.
主要成果:
- 组合疗法消除了多药耐药的P. aeruginosa,而没有诱导进一步的耐药性.
- 木破坏了细菌的铁稳态和细胞能量生产,促进了抗生素的积累.
- 这种组合显示出强大的抗菌疗效,在体外模型中毒性低,并在体内改善生存率.
结论:
- 基于石的药物可以被重新用作治疗P. aeruginosa感染的有效组合疗法.
- 这种方法提高了现有的抗生素的疗效,并打击耐药性.
- 这些发现支持了珠-抗生素组合用于治疗具有挑战性的感染的临床潜力.
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
110
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
110
Antimicrobial Proteins
947
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
947
Factors Influencing Drug Absorption: Disease States and Pharmacology
463
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
463
Antibiotic Selection
52.4K
Overview
52.4K
Drugs for Treatment of Constipation-Predominant IBS
143
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
143


